Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
6,982,600
-
Share change
-
+1,008,356
-
Total reported value
-
$6,904,000
-
Price per share
-
$0.99
-
Number of holders
-
18
-
Value change
-
+$987,728
-
Number of buys
-
11
-
Number of sells
-
5
Institutional Holders of ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) as of Q4 2020
As of 31 Dec 2020,
ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,982,600 shares.
The largest 10 holders included
Canaan Partners X LLC, FRAZIER MANAGEMENT LLC, New Leaf Venture Partners, L.L.C., Pivotal bioVenture Partners Investment Advisor LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, UBS OCONNOR LLC, Focused Wealth Management, Inc, GRIMES & COMPANY, INC., and CLEAR STREET MARKETS LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.